与用于诊断阿尔茨海默病的放射性药物相关的毒性问题。 - Suppr

Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

作者信息

Verma Shristy, Malviya Rishabha, Sridhar Sathvik Belagodu

机构信息

School of Medical and Allied Sciences, Galgotias University, Department of Pharmacy, India.

RAK College of Pharmacy, RAK Medical & Health Sciences University, Clinical Pharmacy and Pharmacology, United Arab Emirates.

出版信息

Cent Nerv Syst Agents Med Chem. 2025;25(2):83-86. doi: 10.2174/0118715249340822240828065449.

DOI:10.2174/0118715249340822240828065449

PMID:39248065

Abstract

摘要

相似文献

Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

Cent Nerv Syst Agents Med Chem. 2025;25(2):83-86. doi: 10.2174/0118715249340822240828065449.

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine.

Curr Radiopharm. 2025;18(1):23-36. doi: 10.2174/0118744710314668240718070109.

Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign.

J Nucl Med. 2004 May;45(5):771-4.

¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Am J Psychiatry. 2002 Mar;159(3):474-6. doi: 10.1176/appi.ajp.159.3.474.

Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108. Epub 2016 May 13.

Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.

Hong Kong Med J. 2016 Aug;22(4):327-33. doi: 10.12809/hkmj154707. Epub 2016 Jun 17.

Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.

Neuroimage. 2012 Mar;60(1):221-9. doi: 10.1016/j.neuroimage.2011.12.071. Epub 2012 Jan 6.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

本文引用的文献

Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.

Braz J Psychiatry. 2022 Aug 15;44(5):495-506. doi: 10.47626/1516-4446-2021-2374.

Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.

J Med Chem. 2022 Jul 14;65(13):8550-8595. doi: 10.1021/acs.jmedchem.1c01619. Epub 2022 Jun 27.

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Int J Mol Sci. 2022 Apr 30;23(9):5023. doi: 10.3390/ijms23095023.

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.

Int J Biol Sci. 2021 May 27;17(9):2181-2192. doi: 10.7150/ijbs.57078. eCollection 2021.

PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

Molecules. 2020 Feb 21;25(4):977. doi: 10.3390/molecules25040977.

Tau PET imaging with F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study.

J Nucl Med. 2020 Jun;61(6):911-919. doi: 10.2967/jnumed.119.236224. Epub 2019 Nov 11.

Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):490-501. doi: 10.1007/s00259-019-04516-z. Epub 2019 Nov 4.

F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease.

Am J Nucl Med Mol Imaging. 2018 Aug 20;8(4):268-281. eCollection 2018.

F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases.

Mol Psychiatry. 2020 Oct;25(10):2608-2619. doi: 10.1038/s41380-018-0203-5. Epub 2018 Aug 17.

Radiotracers for Amyloid Imaging in Neurodegenerative Disease: State-of-the-Art and Novel Concepts.

Curr Med Chem. 2018;25(26):3131-3140. doi: 10.2174/0929867325666180117094704.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献